NYSE

Organon and Co. (OGN)

♥ 598 Thanks from members

Live price chart, market sentiment, and community perspectives for Organon and Co. (NYSE: OGN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: PharmaceuticalsFounder: Merck and Co. (Spin-off)Leadership: Kevin Ali (CEO)Leadership: Matthew Walsh (CFO)Holder: Vanguard GroupHolder: BlackRockHolder: Wellington ManagementNexplanonNuvaRingHadlimaFemara#OGN stock#Organon and Co#womens health pharmaceuticals#NYSE OGN#biosimilars manufacturer